In vivo CRISPR base editing of PCSK9 durably lowers cholesterol in primates

K Musunuru, AC Chadwick, T Mizoguchi, SP Garcia… - Nature, 2021 - nature.com
Gene-editing technologies, which include the CRISPR–Cas nucleases–and CRISPR base
editors,, have the potential to permanently modify disease-causing genes in patients. The …
被引用次数：363 相关文章

In vivo CRISPR base editing of PCSK9 durably lowers cholesterol in primates.

K Musunuru, AC Chadwick, T Mizoguchi, SP Garcia… - Nature, 2021 - europepmc.org
A comment on this article appears in" CRISPR'cousin'put to the test in landmark heart-
disease trial." Nature. 2022 Jul; 607 (7920): 647. A comment on this article appears in" …

[引用][C] In vivo CRISPR base editing of PCSK9 durably lowers cholesterol in primates

K Musunuru, AC Chadwick, T Mizoguchi, SP Garcia… - Nature, 2021 - cir.nii.ac.jp

In vivo CRISPR base editing of PCSK9 durably lowers cholesterol in primates

K Musunuru, AC Chadwick, T Mizoguchi… - …, 2021 - pubmed.ncbi.nlm.nih.gov
Gene-editing technologies, which include the CRISPR-Cas nucleases 1-3 and CRISPR
base editors 4, 5, have the potential to permanently modify disease-causing genes in …

In vivo CRISPR base editing of PCSK9 durably lowers cholesterol in primates

K Musunuru, AC Chadwick, T Mizoguchi, SP Garcia… - Nature, 2021 - ideas.repec.org
Gene-editing technologies, which include the CRISPR–Cas nucleases1–3 and CRISPR
base editors4, 5, have the potential to permanently modify disease-causing genes in …

In vivo CRISPR base editing of PCSK9 durably lowers cholesterol in primates

K Musunuru, AC Chadwick, T Mizoguchi, SP Garcia… - Nature, 2021 - econpapers.repec.org
Gene-editing technologies, which include the CRISPR–Cas nucleases1–3 and CRISPR
base editors4, 5, have the potential to permanently modify disease-causing genes in …

In vivo CRISPR base editing of PCSK9 durably lowers cholesterol in primates

K Musunuru, AC Chadwick, T Mizoguchi, SP Garcia… - paper.sciencenet.cn
Gene-editing technologies, which include the CRISPR–Cas nucleases1, 2, 3 and CRISPR
base editors4, 5, have the potential to permanently modify disease-causing genes in …

In vivo CRISPR base editing of PCSK9 durably lowers cholesterol in primates

K Musunuru, AC Chadwick, T Mizoguchi, SP Garcia… - …, 2021 - ui.adsabs.harvard.edu
Gene-editing technologies, which include the CRISPR-Cas nucleases 1-3 and CRISPR
base editors 4, 5, have the potential to permanently modify disease-causing genes in …